AGP Executive Report
Last update: 9 hours agoH-1B Overhaul in Massachusetts: A federal judge in Massachusetts struck down Trump’s $100,000 fee on new H-1B visa petitions, calling it an unauthorized tax and vacating the requirement nationwide—an immediate win for employers and institutions that rely on skilled foreign talent, with the White House signaling it will appeal. Biotech Deal: GSK agreed to buy Boston-based Nuvalent for $10.6B, adding late-stage lung cancer drugs (ROS1 and ALK inhibitors) under FDA review and aiming to expand oncology growth. Life Sciences Research: PureTech’s Seaport Therapeutics reported positive Phase 1 repeat-dose data for GlyphAgo™ and outlined plans for Phase 2 trials in generalized anxiety disorder. Energy & Markets: A Fed study from Boston found oil price shocks are muting inflation and employment impacts versus the 1970s, even as Middle East supply risks keep energy volatility elevated. Industrial Innovation: Onterris (North Little Rock) will collaborate with Greentown Labs in Somerville to move environmental tech from proof of concept toward pilots. Healthcare & Senior Care: Gardant said 25 managed senior living communities earned AHCA/NCAL Bronze Commitment to Quality Awards, with the company pointing to sustained quality improvement.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
